Earnings Feed
Start Free
Home/Filings/4/0001144204-14-004043
4//SEC Filing

Chelsea Therapeutics International, Ltd. 4

Accession 0001144204-14-004043

CIK 0001333763operating
View on SEC.govCompany Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 8:10 PM ET

Size

15.3 KB

Accession

0001144204-14-004043

Insider Transaction Report

Form 4
Period: 2014-01-22
Chelsea Therapeutics International, Ltd.CHTP
Oliveto Joseph
Vice President of Operations
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-01-22+150,000→ 150,000 total
    Exercise: $4.65Exp: 2024-01-22→ Common Stock (150,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $7.72Exp: 2021-01-11→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (Right to Buy)

    Exercise: $2.96Exp: 2020-01-19→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (Right to Buy)

    Exercise: $5.63Exp: 2018-06-13→ Common Stock (75,000 underlying)
    75,000

  • Common Stock

    3,500

  • Stock Option (Right to Buy)

    Exercise: $0.96Exp: 2023-01-07→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $1.78Exp: 2019-01-22→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (Right to Buy)

    Exercise: $1.24Exp: 2022-07-09→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $4.54Exp: 2022-01-25→ Common Stock (50,000 underlying)
    50,000
Footnotes (8)
  • [F1]Option vests in four equal annual installments beginning on January 22, 2015.
  • [F2]Option vests in four equal annual installments beginning on January 7, 2014.
  • [F3]Option vests in four equal annual installments beginning on July 9, 2013.
  • [F4]Option vests in four equal annual installments beginning on January 25, 2013.
  • [F5]Option vests in four equal annual installments beginning on January 11, 2012.
  • [F6]Option vested in four equal annual installments beginning on January 19, 2011.
  • [F7]Option vested in four equal annual installments beginning on January 22, 2010.
  • [F8]Option vested in four equal annual installments beginning on June 13, 2009.

Documents

1 file

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333763

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:10 PM ET
Size
15.3 KB
View on SEC.gov